Home/Filings/4/0001641172-25-003025
4//SEC Filing

OSMAN RONALD E 4

Accession 0001641172-25-003025

CIK 0001042418other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 5:22 PM ET

Size

7.1 KB

Accession

0001641172-25-003025

Insider Transaction Report

Form 4
Period: 2024-04-01
OSMAN RONALD E
Director10% Owner
Transactions
  • Award

    Common Stock

    2025-04-01+50,00023,554,985 total(indirect: See Footnotes)
Transactions
  • Award

    Common Stock

    2025-04-01+50,00023,554,985 total(indirect: See Footnotes)
Footnotes (2)
  • [F1]Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan.
  • [F2]These shares represent 100,000 shares owned by Mr. Osman and remaining number of shares of common stock held by The Ronald E. Osman Trust III. Mr. Osman is the sole trustee of the Ronald E. Osman Trust III.

Documents

1 file

Issuer

Inhibitor Therapeutics, Inc.

CIK 0001042418

Entity typeother

Related Parties

1
  • filerCIK 0001380466

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 5:22 PM ET
Size
7.1 KB